Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-24-120876

Chief Science & Business Off bought 2,000 shares at $4.99 ($9,980)

From the SEC's structured data for this filing

Trades in this filing

Poradosu Enrique · Chief Science & Business Off

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-19 Purchase : show line 1 in the form +2,000 $4.99 $9,980 1,506,319 D
Open-market purchases · 2,000 sh · avg $4.99 · $9,980
Loading xslF345X05/tm2428944-1_4seq1.xml…